Equities researchers at StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright raised their target price on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Research Report on SNES
SenesTech Stock Down 2.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Read More
- Five stocks we like better than SenesTech
- Stock Market Upgrades: What Are They?
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Buy Cheap Stocks Step by Step
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.